Search clinical trials for: Casodex, Zoladex , Lupron
Total 836 results
-
City of Hope Medical CenterNational Cancer Institute (NCI)Active, not recruitingStage IV Prostate Adenocarcinoma AJCC v7 | PSA Level Greater Than TwoUnited States
-
National Cancer Institute (NCI)CompletedProstate Adenocarcinoma | Recurrent Prostate Carcinoma | Stage IV Prostate CancerUnited States, Canada
-
National Cancer Institute (NCI)CompletedProstate Adenocarcinoma | Stage I Prostate Cancer | Stage III Prostate Cancer | Stage IIA Prostate Cancer | Stage IIB Prostate CancerUnited States
-
Mayo ClinicNational Cancer Institute (NCI)TerminatedProstate Adenocarcinoma | Stage III Prostate Cancer | Stage IV Prostate Cancer | Stage IIA Prostate Cancer | Stage IIB Prostate CancerUnited States
-
National Cancer Institute (NCI)TerminatedProstate Adenocarcinoma | Stage IIA Prostate Cancer AJCC v7 | Stage IIB Prostate Cancer AJCC v7United States
-
Mayo ClinicNational Cancer Institute (NCI)CompletedProstate Adenocarcinoma | Prostate Carcinoma | Recurrent Prostate Carcinoma | Stage III Prostate Cancer | Stage IV Prostate CancerUnited States
-
Dana-Farber Cancer InstituteBeth Israel Deaconess Medical Center; Genentech, Inc.; Brigham and Women's HospitalCompletedProstate CancerUnited States
-
University of Kansas Medical CenterWithdrawnProstate CancerUnited States
-
M.D. Anderson Cancer CenterTerminatedProstate CancerUnited States
-
Barbara Ann Karmanos Cancer InstituteNational Cancer Institute (NCI)CompletedRecurrent Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate CancerUnited States
-
University of California, San FranciscoNational Cancer Institute (NCI)TerminatedProstate AdenocarcinomaUnited States
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI)CompletedProstate CancerUnited States, Canada
-
National Cancer Institute (NCI)CompletedRecurrent Prostate CancerUnited States
-
University of Michigan Rogel Cancer CenterJohns Hopkins University; Washington University School of Medicine; Northwestern... and other collaboratorsCompletedProstate CancerUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingStage IV Prostate Cancer AJCC v8 | Stage IVA Prostate Cancer AJCC v8 | Stage IVB Prostate Cancer AJCC v8 | Metastatic Prostate Adenocarcinoma | Castration-Sensitive Prostate CarcinomaUnited States
-
Schiffler Cancer CenterKent E. Wallner, M.D.; Sylvester, John, M.D.TerminatedProstate CancerUnited States
-
University of Kansas Medical CenterCompletedProstate CancerUnited States
-
NRG OncologyNational Cancer Institute (NCI)Active, not recruitingStage II Prostate Adenocarcinoma | Stage III Prostate Adenocarcinoma | Stage I Prostate AdenocarcinomaUnited States, Canada, Puerto Rico
-
AstraZenecaActive, not recruitingAdvanced Prostate CancerChina
-
Tampere UniversityCompleted
-
AbbottFraktal.com.pl; Med-net.plCompletedLower Urinary Tract Symptoms | Advanced Prostate CancerPoland, Ukraine
-
Ferring PharmaceuticalsCompletedProstate CancerBelgium, Italy, Sweden, Portugal, Denmark, Finland, Norway, Turkey
-
Ferring PharmaceuticalsTerminatedProstate CancerSpain, United Kingdom, Germany
-
AstraZenecaWithdrawn
-
Cancer Center of IrvineUnknown
-
Medical University of South CarolinaCompleted
-
Ferring PharmaceuticalsCompletedProstate CancerSpain, France, United States, Greece, United Kingdom, Germany, Netherlands
-
SOTIO a.s.CompletedProstate CancerCzechia
-
AstraZenecaCompletedBreast CancerThailand, Korea, Republic of, Japan, Philippines, Taiwan, India
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)Active, not recruiting
-
Praful Ravi, MB BCHir, MRCPEli Lilly and Company; BayerActive, not recruitingProstate Cancer | Metastatic Prostate Cancer | Non-metastatic Prostate CancerUnited States
-
Sir Mortimer B. Davis - Jewish General HospitalNot yet recruiting
-
M.D. Anderson Cancer CenterPfizerCompletedProstate CancerUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteSanofiTerminatedProstate CancerUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)WithdrawnBiochemically Recurrent Prostate Carcinoma | Metastatic Prostate Carcinoma | Stage IV Prostate Cancer AJCC v8 | Stage IVA Prostate Cancer AJCC v8 | Stage IVB Prostate Cancer AJCC v8 | Oligometastatic Prostate CarcinomaUnited States
-
Dana-Farber Cancer InstituteBeth Israel Deaconess Medical Center; Brigham and Women's Hospital; Saint Anne... and other collaboratorsCompletedProstate CancerUnited States
-
Medical College of WisconsinActive, not recruiting
-
National Cancer Institute (NCI)TerminatedRecurrent Prostate Cancer | Adenocarcinoma of the ProstateUnited States
-
Fudan UniversityCompleted
-
Ontario Clinical Oncology Group (OCOG)AstraZenecaCompleted
-
Aragon Pharmaceuticals, Inc.Completed
-
Eurofarma Laboratorios S.A.Recruiting
-
M.D. Anderson Cancer CenterActive, not recruitingProstate Adenocarcinoma | Recurrent Prostate CarcinomaUnited States
-
PharmatechWatson Pharmaceuticals; Manyak, Michael, M.D.TerminatedProstate CancerUnited States
-
Endo PharmaceuticalsCompletedProstate Cancer | Adenocarcinoma of the Prostate
-
University of Wisconsin, MadisonNovartis PharmaceuticalsCompletedProstate CancerUnited States
-
Jonsson Comprehensive Cancer CenterJanssen Inc.Active, not recruitingRecurrent Prostate Carcinoma | Stage IVB Prostate Cancer AJCC v8 | Metastatic Prostate Adenocarcinoma | Prostate Adenocarcinoma With Focal Neuroendocrine DifferentiationUnited States
-
Memorial Sloan Kettering Cancer CenterCompletedCancer | Prostate | Hormonal CyclingUnited States
-
UNC Lineberger Comprehensive Cancer CenterSanofiCompleted